1887

Abstract

We have investigated the role of signal transducer and activator of transcription (STAT) 2 during human cytomegalovirus (HCMV) replication and found that protein levels of STAT2 are downregulated. STAT2 downregulation was observed in HCMV clinical isolates and laboratory strains with the exception of strain Towne. The HCMV-induced loss of STAT2 protein occurred despite an increased accumulation of mRNA; it required HCMV early gene expression. The decrease in STAT2 was sensitive to proteasome inhibition, suggesting degradation of STAT2 via the ubiquitin proteasome pathway. Notably, pUL27, the HCMV homologue of the mouse CMV pM27 protein, which mediates the selective proteolysis of STAT2, did not induce STAT2 downregulation. Moreover, preceding STAT2 degradation, alpha/beta interferon (IFN)-receptor-mediated tyrosine phosphorylation of STAT2 was inhibited in HCMV-infected cells. This effect was paralleled by impaired tyrosine activation of STAT1 and STAT3. Accordingly, IFNs affected the replication efficiency of STAT2 degrading and non-degrading HCMV strains to a similar degree. In summary, HCMV abrogates IFN receptor signalling at multiple checkpoints by independent mechanisms including -independent degradation of STAT2 and a preceding blockade of STAT2 phosphorylation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.2008/001669-0
2008-10-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/10/2416.html?itemId=/content/journal/jgv/10.1099/vir.0.2008/001669-0&mimeType=html&fmt=ahah

References

  1. Abenes G., Lee M., Haghjoo E., Tong T., Zhan X., Liu F. 2001; Murine cytomegalovirus open reading frame M27 plays an important role in growth and virulence in mice. J Virol 75:1697–1707 [CrossRef]
    [Google Scholar]
  2. Atalay R., Zimmermann A., Wagner M., Borst E., Benz C., Messerle M., Hengel H. 2002; Identification and expression of human cytomegalovirus transcription units coding for two distinct Fc γ receptor homologs. J Virol 76:8596–8608 [CrossRef]
    [Google Scholar]
  3. Benz C., Reusch U., Muranyi W., Brune W., Atalay R., Hengel H. 2001; Efficient downregulation of major histocompatibility complex class I molecules in human epithelial cells infected with cytomegalovirus. J Gen Virol 82:2061–2070
    [Google Scholar]
  4. Borst E. M., Hahn G., Koszinowski U. H., Messerle M. 1999; Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli : a new approach for construction of HCMV mutants. J Virol 73:8320–8329
    [Google Scholar]
  5. Brierley M. M., Marchington K. L., Jurisica I., Fish E. N. 2006; Identification of GAS-dependent interferon-sensitive target genes whose transcription is STAT2-dependent but ISGF3-independent. FEBS J 273:1569–1581 [CrossRef]
    [Google Scholar]
  6. Caldenhoven E., Buitenhuis M., van Dijk T. B., Raaijmakers J. A., Lammers J. W., Koenderman L., de Groot R. P. 1999; Lineage-specific activation of STAT3 by interferon- γ in human neutrophils. J Leukoc Biol 65:391–396
    [Google Scholar]
  7. Cebulla C. M., Miller D. M., Zhang Y., Rahill B. M., Zimmerman P., Robinson J. M., Sedmak D. D. 2002; Human cytomegalovirus disrupts constitutive MHC class II expression. J Immunol 169:167–176 [CrossRef]
    [Google Scholar]
  8. Chee A. V., Roizman B. 2004; Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J Virol 78:4185–4196 [CrossRef]
    [Google Scholar]
  9. Darnell J. E. Jr 1997; STATs and gene regulation. Science 277:1630–1635 [CrossRef]
    [Google Scholar]
  10. Farrar J. D., Smith J. D., Murphy T. L., Leung S., Stark G. R., Murphy K. M. 2000a; Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2 . Nat Immunol 1:65–69 [CrossRef]
    [Google Scholar]
  11. Farrar J. D., Smith J. D., Murphy T. L., Murphy K. M. 2000b; Recruitment of Stat4 to the human interferon- α / β receptor requires activated Stat2. J Biol Chem 275:2693–2697 [CrossRef]
    [Google Scholar]
  12. Fukao T., Frucht D. M., Yap G., Gadina M., O'Shea J. J., Koyasu S. 2001; Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J Immunol 166:4446–4455 [CrossRef]
    [Google Scholar]
  13. Gil M. P., Bohn E., O'Guin A. K., Ramana C. V., Levine B., Stark G. R., Virgin H. W., Schreiber R. D. 2001; Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A 98:6680–6685 [CrossRef]
    [Google Scholar]
  14. Grey F., Meyers H., White E. A., Spector D. H., Nelson J. 2007; A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog 3:e163 [CrossRef]
    [Google Scholar]
  15. Guma M., Cabrera C., Erkizia I., Bofill M., Clotet B., Ruiz L., Lopez-Botet M. 2006; Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis 194:38–41 [CrossRef]
    [Google Scholar]
  16. Haspel R. L., Salditt-Georgieff M., Darnell J. E. Jr 1996; The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J 15:6262–6268
    [Google Scholar]
  17. Heise M. T., Connick M., Virgin H. W. IV 1998; Murine cytomegalovirus inhibits interferon γ -induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J Exp Med 187:1037–1046 [CrossRef]
    [Google Scholar]
  18. Hengel H., Esslinger C., Pool J., Goulmy E., Koszinowski U. H. 1995; Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 76:2987–2997 [CrossRef]
    [Google Scholar]
  19. Hengel H., Koopmann J. O., Flohr T., Muranyi W., Goulmy E., Hammerling G. J., Koszinowski U. H., Momburg F. 1997; A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6:623–632 [CrossRef]
    [Google Scholar]
  20. Hengel H., Koszinowski U. H., Conzelmann K. K. 2005; Viruses know it all: new insights into IFN networks. Trends Immunol 26:396–401 [CrossRef]
    [Google Scholar]
  21. Horvath C. M. 2004; Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur J Biochem 271:4621–4628 [CrossRef]
    [Google Scholar]
  22. Le V. T., Trilling M., Zimmermann A., Hengel H. 2008; Mouse cytomegalovirus inhibits beta interferon (IFN- β ) gene expression and controls activation pathways of the IFN- β enhanceosome. J Gen Virol 89:1131–1141 [CrossRef]
    [Google Scholar]
  23. Le Roy E., Muhlethaler-Mottet A., Davrinche C., Mach B., Davignon J. L. 1999; Escape of human cytomegalovirus from HLA-DR-restricted CD4+ T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression. J Virol 73:6582–6589
    [Google Scholar]
  24. Lee C. K., Bluyssen H. A., Levy D. E. 1997; Regulation of interferon- α responsiveness by the duration of Janus kinase activity. J Biol Chem 272:21872–21877 [CrossRef]
    [Google Scholar]
  25. Liang X., Shin Y. C., Means R. E., Jung J. U. 2004; Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein. J Virol 78:12416–12427 [CrossRef]
    [Google Scholar]
  26. Lucin P., Pavic I., Polic B., Jonjic S., Koszinowski U. H. 1992; Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol 66:1977–1984
    [Google Scholar]
  27. Lucin P., Jonjic S., Messerle M., Polic B., Hengel H., Koszinowski U. H. 1994; Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol 75:101–110 [CrossRef]
    [Google Scholar]
  28. Miller D. M., Rahill B. M., Boss J. M., Lairmore M. D., Durbin J. E., Waldman J. W., Sedmak D. D. 1998; Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 187:675–683 [CrossRef]
    [Google Scholar]
  29. Miller D. M., Zhang Y., Rahill B. M., Waldman W. J., Sedmak D. D. 1999; Human cytomegalovirus inhibits IFN- α -stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN- α signal transduction. J Immunol 162:6107–6113
    [Google Scholar]
  30. Miller D. M., Zhang Y., Rahill B. M., Kazor K., Rofagha S., Eckel J. J., Sedmak D. D. 2000; Human cytomegalovirus blocks interferon- γ stimulated up-regulation of major histocompatibility complex class I expression and the class I antigen processing machinery. Transplantation 69:687–690 [CrossRef]
    [Google Scholar]
  31. Mocarski E. S., Shenk T., Pass R. F. 2007; Cytomegaloviruses. In Field's Virology , 5th edn. pp 2701–2772Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott, Williams & Wilkins;
    [Google Scholar]
  32. Nguyen K. B., Watford W. T., Salomon R., Hofmann S. R., Pien G. C., Morinobu A., Gadina M., O'Shea J. J., Biron C. A. 2002; Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 297:2063–2066 [CrossRef]
    [Google Scholar]
  33. Paulus C., Krauss S., Nevels M. 2006; A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A 103:3840–3845 [CrossRef]
    [Google Scholar]
  34. Polic B., Hengel H., Krmpotic A., Trgovcich J., Pavic I., Luccaronin P., Jonjic S., Koszinowski U. H. 1998; Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188:1047–1054 [CrossRef]
    [Google Scholar]
  35. Popkin D. L., Watson M. A., Karaskov E., Dunn G. P., Bremner R., Virgin H. W. 2003; Murine cytomegalovirus paralyzes macrophages by blocking IFN- γ induced promoter assembly. Proc Natl Acad Sci U S A 100:14309–14314 [CrossRef]
    [Google Scholar]
  36. Precious B., Childs K., Fitzpatrick-Swallow V., Goodbourn S., Randall R. E. 2005; Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J Virol 79:13434–13441 [CrossRef]
    [Google Scholar]
  37. Presti R. M., Pollock J. L., Dal Canto A. J., O'Guin A. K., Virgin H. W. IV 1998; Interferon γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 188:577–588 [CrossRef]
    [Google Scholar]
  38. Sinzger C., Schmidt K., Knapp J., Kahl M., Beck R., Waldman J., Hebart H., Einsele H., Jahn G. 1999; Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol 80:2867–2877
    [Google Scholar]
  39. Sinzger C., Hahn G., Digel M., Katona R., Sampaio K. L., Messerle M., Hengel H., Koszinowski U., Brune W., Adler B. 2008; Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 89:359–368 [CrossRef]
    [Google Scholar]
  40. Stark G. R., Kerr I. M., Williams B. R., Silverman R. H., Schreiber R. D. 1998; How cells respond to interferons. Annu Rev Biochem 67:227–264 [CrossRef]
    [Google Scholar]
  41. Stenberg R. M., Depto A. S., Fortney J., Nelson J. A. 1989; Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J Virol 63:2699–2708
    [Google Scholar]
  42. Stinski M. F. 1976; Human cytomegalovirus: glycoproteins associated with virions and dense bodies. J Virol 19:594–609
    [Google Scholar]
  43. Torpey N., Maher S. E., Bothwell A. L., Pober J. S. 2004; Interferon α but not interleukin 12 activates STAT4 signaling in human vascular endothelial cells. J Biol Chem 279:26789–26796 [CrossRef]
    [Google Scholar]
  44. Wagner M., Gutermann A., Podlech J., Reddehase M. J., Koszinowski U. H. 2002; Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med 196:805–816 [CrossRef]
    [Google Scholar]
  45. White E. A., Spector D. H. 2005; Exon 3 of the human cytomegalovirus major immediate-early region is required for efficient viral gene expression and for cellular cyclin modulation. J Virol 79:7438–7452 [CrossRef]
    [Google Scholar]
  46. Zimmermann A., Hengel H. 2006; Cytomegalovirus interference with interferons. In Cytomegaloviruses: Molecular Biology and Immunology . pp 321–339Edited by Reddehase M. J. Wymondham, UK: Caister Academic Press;
  47. Zimmermann A., Trilling M., Wagner M., Wilborn M., Bubic I., Jonjic S., Koszinowski U., Hengel H. 2005; A cytomegaloviral protein reveals a dual role for STAT2 in IFN- γ signaling and antiviral responses. J Exp Med 201:1543–1553 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.2008/001669-0
Loading
/content/journal/jgv/10.1099/vir.0.2008/001669-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error